C. Cripps

5.1k citations
58 papers · 3.9k · 2 hit papers · h-index 20

Impact in

  • Oncology top 1%
    • Pancreatic and Hepatic Oncology Research
    • Cancer Immunotherapy and Biomarkers
    • Colorectal Cancer Treatments and Studies
    • Head and Neck Cancer Studies

Papers in

    • Colorectal Cancer Treatments and Studies 21
    • Cancer Treatment and Pharmacology 8
    • Colorectal Cancer Surgical Treatments 6
    • Pancreatic and Hepatic Oncology Research 6
    • Head and Neck Cancer Studies 7

C. Cripps

58 papers receiving 3.8k citations

C. Cripps's Hit Papers

Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer 2022 · 223 citations
2230+2+5Years since publication50010001.5k2.0k

Peers

C. Cripps
Comparison fields: 5 of 113
  • Oncology 2.6k
  • Otorhinolaryngology 222
  • Cancer Research 611
  • Pulmonary and Respiratory Medicine 679
  • Surgery 516
Replace Andreas Schalhorn with:
Andreas Schalhorn Germany
Charles John Schneider United States
Mary Cabiddu Italy
John Philip Kuebler United States
Enzo Maria Ruggeri Italy
Richard James Battafarano United States
Karen Borgonovo Italy
Joseph N. Kerger Belgium
Stelios Kakolyris Greece
Francisco Robert United States
C. Cripps relative to Andreas Schalhorn Germany Andreas Schalhorn's profile →
Citations per field
00.5×2×4×6×8.8×
Andreas Schalhorn · 1×
Citations per year

Countries citing papers authored by C. Cripps

Since Specialization
Citations

This map shows the geographic impact of C. Cripps's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Cripps with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Cripps more than expected).

Fields of papers citing papers by C. Cripps

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Cripps. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Cripps. The network helps show where C. Cripps may publish in the future.

Co-authors

The 25 scholars most cited alongside C. Cripps, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with C. Cripps Line = papers co-authored together C. Cripps links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 58 papers — load more, or switch the sort, to bring in the rest.

#Work
1
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
Hit paper breakdown →
20182161
2
Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
Hit paper breakdown →
2022223
3 2016221
4 1993140
5 2006132
6 1994119
7 200898
8 199989
9 196883
10 201067
11 200857
12 196954
13 199238
14 200834
15 199626
16 200324
17 200224
18 200121
19
A randomized comparison of cyclophosphamide-mitoxantrone-5-fluorouracil v cyclophosphamide-doxorubicin-5-fluorouracil in advanced breast cancer: preliminary observations.
198421
20 201420

About C. Cripps

C. Cripps is a scholar working on Oncology, Otorhinolaryngology, Pulmonary and Respiratory Medicine, Hepatology and Pathology and Forensic Medicine, having authored 58 papers that have together received 3.9k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (21 papers), Cancer Treatment and Pharmacology (8 papers), Gastric Cancer Management and Outcomes (8 papers), Head and Neck Cancer Studies (7 papers), Colorectal Cancer Surgical Treatments (6 papers), Pancreatic and Hepatic Oncology Research (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers) and Lung Cancer Treatments and Mutations (4 papers). The work is most often cited by research in Oncology (2.6k citations), Otorhinolaryngology (222 citations), Cancer Research (611 citations), Pulmonary and Respiratory Medicine (679 citations) and Surgery (516 citations). C. Cripps has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Mark N. Levine, D. Ian Hodson, George P. Browman, Jinka Sathya, Libne Eapen, Sharlene Gill, Scot D. Dowden, Yoo‐Joung Ko, Peter Skingley and Malcolm J. Moore. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics, Annals of Oncology, Journal of Surgical Oncology and Cancer Chemotherapy and Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact